Concepedia

Tim P.D. Oostendorp

TP

Statistics

Publications

1

Citations

111

H-Index

1

Active since

2015

Affiliations

AstraZeneca (United Kingdom)(Current)

Tim P.D. Oostendorp is an author at AstraZeneca (United Kingdom) specializing in radiation oncology, cancer research, and radiation therapy.

Top concepts

Publications per year

2015–2015

1

Publications

1

Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells

Caroline V.M. Verhagen, Rosemarie de Haan, Floor Hageman et al. · Radiotherapy and Oncology · 2015 · 111 citations

, , +10

1–1 of 1